Oral Anticoagulation in 2024: Lessons from Randomized Trials

Explore the latest insights on oral anticoagulation in this comprehensive grand rounds presentation by Professor John Eikelboom from McMaster University. Delve into crucial lessons drawn from randomized trials as Dr. Eikelboom, a senior investigator at the Population Health Research Institute, shares his expertise on the current state and future directions of anticoagulation therapy. Gain valuable knowledge about the evolving landscape of oral anticoagulants, their efficacy, safety profiles, and potential implications for clinical practice in 2024 and beyond. This 56-minute lecture offers a unique opportunity to stay abreast of cutting-edge developments in the field of anticoagulation management, essential for healthcare professionals involved in treating patients with thromboembolic disorders.

Oral Anticoagulation in 2024: Lessons from the randomized trials - Grand Rounds